SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
18359663
Source:
http://linkedlifedata.com/resource/pubmed/id/18359663
Search
Subject
(
58
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0001899
,
umls-concept:C0087111
,
umls-concept:C0201836
,
umls-concept:C0376147
,
umls-concept:C0376705
,
umls-concept:C0524909
,
umls-concept:C0796545
,
umls-concept:C2257651
pubmed:issue
2
pubmed:dateCreated
2008-5-30
pubmed:abstractText
Alanine aminotransferase (ALT) is one of the main indicators for inflammatory activity in chronic hepatitis B. During interferon-based therapy, approximately 25%-40% of patients exhibit an ALT flare.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/9815671
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Alanine Transaminase
,
http://linkedlifedata.com/resource/pubmed/chemical/Antiviral Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/DNA, Viral
,
http://linkedlifedata.com/resource/pubmed/chemical/Hepatitis B e Antigens
,
http://linkedlifedata.com/resource/pubmed/chemical/Interferon-alpha
,
http://linkedlifedata.com/resource/pubmed/chemical/Polyethylene Glycols
,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins
,
http://linkedlifedata.com/resource/pubmed/chemical/interferon alfa-2b
,
http://linkedlifedata.com/resource/pubmed/chemical/peginterferon alfa-2b
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
1386-6532
pubmed:author
pubmed-author:BigotGG
,
pubmed-author:HaagmansB LBL
,
pubmed-author:HanselB CBC
,
pubmed-author:JanssenH L AHL
,
pubmed-author:ter BorgM JMJ
pubmed:issnType
Print
pubmed:volume
42
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
160-4
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:18359663-Adult
,
pubmed-meshheading:18359663-Alanine Transaminase
,
pubmed-meshheading:18359663-Antiviral Agents
,
pubmed-meshheading:18359663-DNA, Viral
,
pubmed-meshheading:18359663-Female
,
pubmed-meshheading:18359663-Hepatitis B, Chronic
,
pubmed-meshheading:18359663-Hepatitis B e Antigens
,
pubmed-meshheading:18359663-Hepatitis B virus
,
pubmed-meshheading:18359663-Humans
,
pubmed-meshheading:18359663-Interferon-alpha
,
pubmed-meshheading:18359663-Male
,
pubmed-meshheading:18359663-Middle Aged
,
pubmed-meshheading:18359663-Polyethylene Glycols
,
pubmed-meshheading:18359663-Recombinant Proteins
,
pubmed-meshheading:18359663-Treatment Outcome
,
pubmed-meshheading:18359663-Viral Load
pubmed:year
2008
pubmed:articleTitle
ALT and viral load decline during PEG-IFN alpha-2b treatment for HBeAg-positive chronic hepatitis B.
pubmed:affiliation
Department of Gastroenterology and Hepatology, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, The Netherlands.
pubmed:publicationType
Journal Article